1Kitagawa Y,Ueda M,Ando N,et al.Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma[J].Clin Cancer Res,1996,2 (5):909-914.
2Wilkinson N W,Black J D,Roukhadze E,et al.Epidermal growth factor receptor expression correlates with histologic grade in resected esophageal adenocarcinoma[J].J Gastrointest Surg,2004,8 (4):448-453.
3Janmaat M L,Gallegos-Ruiz M Ⅰ,Rodriguez J A,et al.Predictive factors for outcome in a phase Ⅱ study of Gefitinib in second-line treatment of advanced esophageal cancer patients[J].J Clin Oncol,2006,24 (10):1612-1619.
4Ferry D R,Anderson M,Beddard K,et al.A phase Ⅱ study of Gefitinib monotherapy in advanced esophageal adenocarcinoma:evidence of gene expression,cellular,and clinical response[J].Clin Cancer Res,2007,13 (19):5869-5875.
5Van Groeningen C,Richel D,Giaccone G.Gefitinib phase Ⅱ study in second line treatment of advanced esophageal cancer[J].J Clin Oncol,2004,22 (14S):4022.
6Juergens R A,Gibson M K,Yang S C,et al.Phase Ⅱ study of neoadjuvant and adjuvant gefitinib (G) with neoadjuvant chemoradiotherapy (CRT) in operable esophageal adenocarcinoma (EAC)[J].J Clin Oncol,2010,28(Suppl):Abstr e14532.
7Javle M,Pande A,Iver R,et al.Pilot study of Gefitinib,Oxaliplatin,and radiotherapy for esophageal adenocarcinoma tissue effect predicts clinical response[J].Am J Clin Oncol,2008,31 (4):329-334.
8Rodriquez C P,Adelstein D J,Rice T W,et al.A phase Ⅱ study of perioperative concurrent chemotherapy,Gefitinib,and hyperfractionated radiation followed by maintenance Gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer[J].J Thorac Oncol,2010,5 (2):229-235.
9Dragovich T,McCoy S,Fenoglio-Preiser C M,et al.Phase Ⅱ trial of Erlotinib in gastroesophageal junction and gastric denocarcinomas:SWOG 0127[J].J Clin Oncol,2006,24 (30):4922-4927.
10Dobelbower M C,Russo S M,Raisch K P,et al.Epidermal growth factor receptor tyrosine kinase inhibitor,erlotinib,and concurrent 5-fluorouracil,cisplatin and radiotherapy for patients with esophageal cancer:a phase Ⅰ study[J].Anticancer Drugs,2006,17 (1):95-102.
